Characterizing potential genotoxicity of compounds – Screening to IND
Syngene’s genetic toxicology department helps clients characterize the potential genotoxicity of compounds from screening to investigational new drug (IND) submission. Our team of experienced analytical and bioanalytical specialists, toxicologists, and statisticians has been supporting genetic toxicology studies since 2010. Over the last two years, we completed more than 300 genetic toxicology studies for our partners.
We offer a range of in vitro toxicology studies that are more predictive of human response, enable a quicker turnaround time, provide standalone data for specific endpoints, and help screen and rank chemicals by studying specific targets in cells and tissues.